Lifecycle Continuity Through Regulatory Compliance: A Comparative Evaluation of Post-Approval Change Strategies for APIs and Drug Products Under the Regulatory Frameworks of Saudi Arabia, the United States, Australia, and Eurasia
| dc.contributor.author | Sharlee Krunalkumar Shah | |
| dc.contributor.author | Vinit Movaliya | |
| dc.contributor.author | Zuki Patel | |
| dc.contributor.author | Maitreyi Zaveri | |
| dc.contributor.author | Akshita Parekh | |
| dc.contributor.author | Niranjan Kanaki | |
| dc.date.accessioned | 2026-06-22T06:28:59Z | |
| dc.date.issued | 2026-06-15 | |
| dc.identifier.issn | 2321-6794 | |
| dc.identifier.uri | http://160.160.1.15:4000/handle/123456789/455 | |
| dc.language.iso | en | |
| dc.publisher | Diva Enterprises Pvt. Ltd. | |
| dc.title | Lifecycle Continuity Through Regulatory Compliance: A Comparative Evaluation of Post-Approval Change Strategies for APIs and Drug Products Under the Regulatory Frameworks of Saudi Arabia, the United States, Australia, and Eurasia | |
| dc.type | Article |
